Literature DB >> 11559467

Recent Considerations in Recurrent Cellulitis.

Larry M. Baddour1.   

Abstract

Cellulitis is a frequently diagnosed syndrome that causes considerable morbidity. For a subset of patients, recurrent bouts of infection impact their quality of life. Most cases are due to beta-hemolytic streptococci or Staphylococcus aureus. Inclusion of interdigital space (toe web) or mucosal (anal) swab cultures may increase the ability to define pathogens among patients with lower extremity cellulitis. The pathogenesis of cellulitis is complex, and more work is needed so that novel therapies and vaccines can be developed to improve treatment and prevention of this disorder.

Entities:  

Year:  2001        PMID: 11559467

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  5 in total

1.  Optimal management of uncomplicated skin and skin structure infections of the lower extremity.

Authors:  Warren S Joseph
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

2.  Teaching self-management skills in persons with chronic lower limb swelling and limited mobility: evidence for usability of telerehabilitation.

Authors:  Becky L Faett; David M Brienza; Mary Jo Geyer; Leslie A Hoffman
Journal:  Int J Telerehabil       Date:  2013-06-11

3.  A Woman with Unilateral Rash and Fever: Cellulitis in the Setting of Lymphedema.

Authors:  Melissa Joseph; Marissa Camilon; Tarina Kang
Journal:  Case Rep Emerg Med       Date:  2015-06-11

4.  Design and development of a telerehabilitation self-management program for persons with chronic lower limb swelling and mobility limitations: preliminary evidence.

Authors:  Becky L Faett; Mary Jo Geyer; Leslie A Hoffman; David M Brienza
Journal:  Nurs Res Pract       Date:  2012-11-27

5.  Dermatology for the practicing allergist: Tinea pedis and its complications.

Authors:  Muhannad Al Hasan; S Matthew Fitzgerald; Mahnaz Saoudian; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2004-03-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.